Alpine Associates Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Alpine Associates Management’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-743,397	Closed	-$50.6M	–	59
2022 Q3	$50.6M	Buy	+743,397	New	+$41M	2.1%	17

Other funds holding GBT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Alpine Associates Management's GBT Position: Q4 2022 in Review

Alpine Associates Management sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 743,397 shares — an estimated $50.6M sold.

Alpine Associates Management first reported a position in GBT in Q3 2022 and held it in 1 quarter. The position peaked at $50.6M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

Alpine Associates Management reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
Alpine Associates Management sold 743,397 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $50.6M.
Alpine Associates Management first reported a position in Global Blood Therapeutics, Inc. in Q3 2022 and held it in 1 quarter.
Alpine Associates Management's Global Blood Therapeutics, Inc. position peaked at $50.6M in Q3 2022.
2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Alpine Associates Management's 13F filing for Q4 2022, filed 8 Feb 2023.